Annual Report on Form 10-K for the year ended 31 December 2024
26 March 2025
Results, Reports and Presentations
UK Annual Report 2024
26 March 2025
UK Annual Report 2023
25 April 2024
Annual Report on Form 10-K for the year ended 31 December 2023
27 March 2024
Condensed Consolidated Financial Statements (unaudited)
07 September 2023
Annual Report 2022
28 March 2023
Condensed Consolidated Financial Statements (unaudited)
02 November 2022
Alvelestat R&D Update Call
31 October 2022
Mereo BioPharma announces Positive Top-Line Efficacy and Safety Data from “ASTRAEUS” Phase 2 Trial of Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Emphysema
09 May 2022
Annual Report 2021
01 April 2022
Mereo BioPharma to Hold Virtual R&D Day on Monday, March 14, 2022
14 March 2022
Mereo Reports Interim Data from ACTIVATE Phase 1b/2 Study of Etigilimab
30 November 2021
Unaudited Condensed Consolidated Financial Statements as of June 30 2021
08 November 2021
Mereo to Participate in Fireside Chat at the Jefferies Healthcare Conf.
03 June 2021
Mereo BioPharma to Hold Virtual R&D Day on Thursday, May 13, 2021
13 May 2021
Annual Report 2020
16 April 2021
Needham Healthcare Conference, April 12-15, 2021
12 April 2021
Mereo BioPharma Reports Full Year 2020 Financial Results and Recent Highlights
31 March 2021
SVB Leerink Fireside Chat - Thursday, February 25, 2021 at 8:00am Eastern Time
25 February 2021
Virtual R&D Day
24 November 2020
Mereo BioPharma to Present at the Stifel 2020 Virtual Healthcare Conference
16 November 2020
2020 Interim Financial Results Webcast
29 September 2020
Annual Report 2019
16 June 2020